Panacea Biotec Limited (NSE:PANACEABIO)
India
· Delayed Price · Currency is INR 444.55
-6.45 (-1.43%)
Jun 16, 2025, 10:30 AM IST
Panacea Biotec Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Net Income | -83.7 | -11.73 | -332.37 | 10,783 | -1,477 | Upgrade
|
| Depreciation & Amortization | 348.1 | 367.11 | 391.23 | 430.34 | 447.76 | Upgrade
|
| Other Amortization | - | - | - | 7.43 | 8.18 | Upgrade
|
| Loss (Gain) From Sale of Assets | -4.5 | 45.59 | -22.99 | -0.07 | 0.38 | Upgrade
|
| Asset Writedown & Restructuring Costs | 13.9 | - | - | 15.75 | 42.63 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | - | -0.77 | Upgrade
|
| Provision & Write-off of Bad Debts | 13.3 | 11.09 | 23.87 | 8.98 | 23.29 | Upgrade
|
| Other Operating Activities | -474.9 | -509.95 | -915.15 | -15,339 | 1,807 | Upgrade
|
| Change in Accounts Receivable | -158.4 | 29.56 | 68.94 | -463.4 | -168.57 | Upgrade
|
| Change in Inventory | -357.4 | 241.58 | 106.3 | -385.8 | -264.45 | Upgrade
|
| Change in Other Net Operating Assets | 429.9 | -174.25 | -3,544 | 3,858 | 652.1 | Upgrade
|
| Operating Cash Flow | -273.7 | -1 | -4,225 | -1,084 | 1,067 | Upgrade
|
| Capital Expenditures | -503.1 | -777.18 | -409.46 | -125.1 | -217.63 | Upgrade
|
| Sale of Property, Plant & Equipment | 5.8 | 66.83 | 395.05 | 20 | 42.56 | Upgrade
|
| Divestitures | - | - | - | 18,220 | - | Upgrade
|
| Investment in Securities | 1,029 | 728.81 | 4,197 | -5,322 | -336.03 | Upgrade
|
| Other Investing Activities | 117.8 | 83.81 | 120.62 | 32.8 | 34.31 | Upgrade
|
| Investing Cash Flow | 649.8 | 102.27 | 4,303 | 12,826 | -476.79 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 2.96 | 1,012 | Upgrade
|
| Total Debt Issued | - | - | - | 2.96 | 1,012 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -35.68 | Upgrade
|
| Long-Term Debt Repaid | - | -2.36 | -147.74 | -7,864 | -453.46 | Upgrade
|
| Total Debt Repaid | - | -2.36 | -147.74 | -7,864 | -489.14 | Upgrade
|
| Net Debt Issued (Repaid) | - | -2.36 | -147.74 | -7,861 | 522.86 | Upgrade
|
| Other Financing Activities | -26.6 | -25.72 | -35.99 | -3,898 | -993.96 | Upgrade
|
| Financing Cash Flow | -26.6 | -28.08 | -183.73 | -11,759 | -471.1 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.1 | 0.03 | -0.04 | -0.13 | - | Upgrade
|
| Net Cash Flow | 349.6 | 73.22 | -104.98 | -17.42 | 118.61 | Upgrade
|
| Free Cash Flow | -776.8 | -778.18 | -4,634 | -1,210 | 848.87 | Upgrade
|
| Free Cash Flow Margin | -13.89% | -13.92% | -100.75% | -18.29% | 13.59% | Upgrade
|
| Free Cash Flow Per Share | -12.71 | -12.71 | -75.66 | -19.75 | 13.86 | Upgrade
|
| Cash Interest Paid | 26.6 | 25.72 | 35.99 | 3,898 | 993.96 | Upgrade
|
| Cash Income Tax Paid | 9.6 | 25.06 | 24.77 | 4,037 | 9.95 | Upgrade
|
| Levered Free Cash Flow | -1,039 | -651.53 | -4,293 | 2,811 | 1,882 | Upgrade
|
| Unlevered Free Cash Flow | -1,015 | -634.82 | -4,269 | 3,935 | 3,037 | Upgrade
|
| Change in Net Working Capital | 480.18 | -34.43 | 3,609 | -3,925 | -2,531 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.